Related Experiment Videos
[Is it necessary to treat silent myocardial ischemia?]
1Kardiologischen Abteilung, Medizinischen Universitätsklinik Graz.
Insights
Currently, no strong evidence supports treating silent myocardial ischemia with anti-ischemic drugs. These episodes indicate coronary artery disease but do not improve prognosis with standard antianginal medications.
Area of Science:
- Cardiology
- Ischemic Heart Disease
- Clinical Evidence
Context:
- Silent myocardial ischemia, detected via exercise or Holter ECG, is a recognized indicator of coronary artery disease (CAD).
- Despite being a marker of poor prognosis, the benefit of anti-ischemic drug therapy for silent episodes remains unproven.
Purpose:
- To evaluate the current evidence for treating silent myocardial ischemia with anti-ischemic drugs.
- To clarify the prognostic significance of silent ischemic episodes and guide management strategies.
Summary:
- There is no definitive evidence that anti-ischemic drugs improve outcomes in patients with silent myocardial ischemia.
- Antianginal drugs like nitrates, calcium-blockers, and beta-blockers have not demonstrated a prognostic benefit for silent ischemic episodes.
- Further evaluation with thallium scintigraphy and coronary angiography is recommended for patients experiencing ischemic episodes.
Impact:
- This review highlights the need for evidence-based treatment decisions in managing silent myocardial ischemia.
- It emphasizes established therapies for significant coronary artery disease, including risk factor modification, lipid-lowering drugs, aspirin, and revascularization procedures (PTCA, CABG).
- Guides clinicians on appropriate diagnostic workup and therapeutic pathways for patients with silent ischemic episodes.
Abstract:
At the present time there is no firm evidence that silent myocardial ischemia (on exercise or Holter ECG) should be treated with anti-ischemic drugs. Silent ischemic episodes obviously are a marker for ischemic activity of coronary artery disease and therefore a bad prognostic sign. However, antianginal drugs (nitrates, calcium-blockers, beta-blockers) have not been shown to improve prognosis. Patients with ischemic episodes should be further evaluated by thallium scintigraphy and coronary angiography. If a significant coronary disease is present, the established therapy with risk factor reduction, lipid lowering drugs and aspirin should be administered. In some instances PTCA or CABG may be indicated.